These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 34638776)

  • 21. Contribution of the Immune Response to Phage Therapy.
    Krut O; Bekeredjian-Ding I
    J Immunol; 2018 May; 200(9):3037-3044. PubMed ID: 29685950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation and characterization of broad spectrum bacteriophages lytic to Vibrio harveyi from shrimp farms of Kerala, India.
    Surekhamol IS; Deepa GD; Somnath Pai S; Sreelakshmi B; Varghese S; Bright Singh IS
    Lett Appl Microbiol; 2014 Mar; 58(3):197-204. PubMed ID: 24131105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacteriophages against Vibrio coralliilyticus and Vibrio tubiashii: Isolation, Characterization, and Remediation of Larval Oyster Mortalities.
    Richards GP; Watson MA; Madison D; Soffer N; Needleman DS; Soroka DS; Uknalis J; Baranzoni GM; Church KM; Polson SW; Elston R; Langdon C; Sulakvelidze A
    Appl Environ Microbiol; 2021 Apr; 87(10):. PubMed ID: 33674441
    [No Abstract]   [Full Text] [Related]  

  • 24. Metagenomic Analysis of Therapeutic PYO Phage Cocktails from 1997 to 2014.
    Villarroel J; Larsen MV; Kilstrup M; Nielsen M
    Viruses; 2017 Nov; 9(11):. PubMed ID: 29099783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phage Tail-Like Bacteriocins.
    Scholl D
    Annu Rev Virol; 2017 Sep; 4(1):453-467. PubMed ID: 28961412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation of lytic bacteriophage against Vibrio harveyi.
    Crothers-Stomps C; Høj L; Bourne DG; Hall MR; Owens L
    J Appl Microbiol; 2010 May; 108(5):1744-50. PubMed ID: 19886890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host exopolysaccharide quantity and composition impact Erwinia amylovora bacteriophage pathogenesis.
    Roach DR; Sjaarda DR; Castle AJ; Svircev AM
    Appl Environ Microbiol; 2013 May; 79(10):3249-56. PubMed ID: 23503310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and Characterization of Lytic Bacteriophages from Wastewater with Phage Therapy Potentials Against Gram-Negative Bacteria.
    Khorshidtalab M; Durukan İ; Tufekci EF; Nas SS; Abdurrahman MA; Kiliç AO
    Eurasian J Med; 2022 Jun; 54(2):157-164. PubMed ID: 35703524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. |Isolation and characterization of novel bacteriophages as a potential therapeutic option for Escherichia coli urinary tract infections.
    González-Villalobos E; Ribas-Aparicio RM; Montealegre GER; Belmont-Monroy L; Ortega-García Y; Aparicio-Ozores G; Balcázar JL; Eslava-Campos CA; Hernández-Chiñas U; Molina-López J
    Appl Microbiol Biotechnol; 2021 Jul; 105(13):5617-5629. PubMed ID: 34254156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel lytic bacteriophages of Klebsiella oxytoca ABG-IAUF-1 as the potential agents for mastitis phage therapy.
    Amiri Fahliyani S; Beheshti-Maal K; Ghandehari F
    FEMS Microbiol Lett; 2018 Oct; 365(20):. PubMed ID: 30212876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation, characterization, and efficacy of bacteriophages isolated against Citrobacter spp. an in vivo approach in a zebrafish model (Danio rerio).
    Madurantakam Royam M; Nachimuthu R
    Res Microbiol; 2020 Dec; 171(8):341-350. PubMed ID: 32919052
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Jet nebulization of bacteriophages with different tail morphologies - Structural effects.
    Leung SSY; Carrigy NB; Vehring R; Finlay WH; Morales S; Carter EA; Britton WJ; Kutter E; Chan HK
    Int J Pharm; 2019 Jan; 554():322-326. PubMed ID: 30445174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classification of Acinetobacter phages.
    Ackermann HW; Brochu G; Emadi Konjin HP
    Arch Virol; 1994; 135(3-4):345-54. PubMed ID: 7979972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteriophages of lactobacillus.
    Villion M; Moineau S
    Front Biosci (Landmark Ed); 2009 Jan; 14(5):1661-83. PubMed ID: 19273154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic Characterization, Formulation and Efficacy in Planta of a
    Zaczek-Moczydłowska MA; Young GK; Trudgett J; Fleming CC; Campbell K; O'Hanlon R
    Viruses; 2020 Jan; 12(2):. PubMed ID: 32012814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new bacteriophage typing scheme for Proteus mirabilis and Proteus vulgaris strains. 3. Analysis of lytic properties.
    Sekaninová G; Rychlík I; Kolárová M; Pillich J; Seménka J; Zajícová V
    Folia Microbiol (Praha); 1998; 43(2):136-40. PubMed ID: 9721605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and characterization of two lytic bacteriophages against Staphylococcus aureus from India: newer therapeutic agents against Bovine mastitis.
    Ganaie MY; Qureshi S; Kashoo Z; Wani SA; Hussain MI; Kumar R; Maqbool R; Sikander P; Banday MS; Malla WA; Mondal P; Khan RIN
    Vet Res Commun; 2018 Dec; 42(4):289-295. PubMed ID: 30219981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic characterization of key bacteriophages to formulate the potential biocontrol agent to combat enteric pathogenic bacteria.
    Parmar KM; Dafale NA; Tikariha H; Purohit HJ
    Arch Microbiol; 2018 May; 200(4):611-622. PubMed ID: 29330592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.